Background {#Sec1}
==========

Pancreatoduodenectomy (PD) is advocated for treating most malignant and benign neoplasms of the pancreatic head and periampullary region \[[@CR1]\]. PD procedures can be performed in high-volume medical centers with a mortality rate of \< 5% and an up to 50% risk of perioperative complications \[[@CR2], [@CR3]\]. Postoperative pancreatic fistula (POPF) is a common complication of pancreaticojejunostomy and its occurrence remains considerable, ranging from 13 to 41% \[[@CR4], [@CR5]\]. The occurrence of a clinically relevant (CR)-POPF has been advocated as a trigger factor for developing secondary complications, such as post-pancreatectomy hemorrhage, infections, and postoperative failure to thrive \[[@CR6]\].

Several factors contribute to the development of a POPF, and every pancreatic surgeon must be aware of these factors. Patient-related factors can influence POPF development, including soft pancreatic tissue, a small pancreatic duct diameter of \< 3 mm, and a body mass index ≥25 kg/m^2^, and have been proven to be independent risk factors for POPF \[[@CR7]--[@CR10]\]. Moreover, technical and perioperative factors also contribute to the development of POPF.

In this report, we present one case of Grade-C POPF after pancreaticojejunostomy due to the completion of anastomosis in the upper mesenteric vessels behind the jejunum loop obstruction extraction, along with a review of the literature.

Case presentation {#Sec2}
=================

A 68-year-old man was admitted to our ward with intermittent epigastric distention for more than 1 month. The patient underwent surgery for penile cancer 21 years ago. The physical examination was unremarkable, with the exception of slight tenderness in the right upper abdomen. The patient's height was 175 cm, weight was 70 kg, and body mass index (BMI) was 22.86. The initial laboratory results showed: total bilirubin (TBIL) 17.9 umol/L, direct bilirubin (DBIL) 9.3 umol/L, alanine aminotransferase (ALT) 526.5 U/L, aspartic aminotransferase (AST) 302.1 U/L, alkaline phosphatase 1756.6 U/L, glutamyl transpeptidase (GGT) 2240.6 U/L, and carbohydrate 19--9 (CA19--9) 26.11 u/ml. The initial leucocyte count, platelet count, renal function, coagulation profile, and other electrolytes were normal. Upper abdominal magnetic resonance imaging (MRI) showed local wall thickening enhanced in the upper pancreatic segment of the common bile duct and lumen stenosis, mostly considering choledochal carcinoma, with upper bile duct dilation and without evidence of invasion of the superior mesenteric vessels and metastasis (Fig. [1](#Fig1){ref-type="fig"}). A malignant tumor of the common bile duct was diagnosed preoperatively. Due to the elevated level of ALT in the patient, reduced glutathione was administered to protect the liver function. However, a week later, the ALT level was 840.6 U/L; thus, endoscopic retrograde cholangiopancreatography (ERCP) and nasal bile duct drainage were performed. Four days after ERCP, the ALT and AST levels decreased to 840.6 U/L and 38.4 U/L, respectively, and PD was performed on the fifth day after ERCP. The distal stomach, gallbladder, common bile duct, pancreatic head, and a small part of the jejunum were removed. The distal jejunum was lifted up behind the superior mesenteric vessels to the superior colonic region, then pancreaticojejunostomy, chojejunostomy, gastrojejunostomy, and Braun jejunostomy were completed successively. The pancreaticojejunostomy was conducted using the duct-to-mucosa method (Fig. [2](#Fig2){ref-type="fig"}), and the chojejunostomy, gastrojejunostomy, and Braun jejunostomy were performed using the running suturing technique. Intraoperative findings revealed soft pancreatic texture and pancreatic duct was 3 mm. Fig. 1MRI showed local wall thickens and enhanced in the supper pancreatic segment of the common bile duct, and lumen is stenosis, mostly likely choledochal carcinoma, with upper bile duct dilatationFig. 2Pancreaticojejunostomy at completion of surgery

On postoperative day (POD) 1, the endotracheal intubation was removed and gastrointestinal function was restored. A liquid diet was then given on POD 5 and a semi-liquid diet was given on POD 7. During this process, the vital signs and drainage amylase test results of the patient were normal. On POD 9, the patient suddenly experienced severe epigastric pain accompanied by nausea and vomiting. Physical examination revealed tension in the abdominal muscles, tenderness throughout the abdomen, and rebound pain. The patient's heart rate was 130 beats/minute, blood pressure (BP) was 106/67 mmHg, leucocyte count was 8.25 × 10^9^ cells/L, and drainage amylase level was 21.8 U/L. Emergency total abdominal computed tomography (CT) showed a small amount of fluid in the abdominal and pelvic cavities, a dilated bowel, and effusion in the upper abdominal bowel cavity, which was considered to be an obstruction. The patient was admitted to the intensive care unit and received conservative treatment, including fasting, gastrointestinal decompression, anti-infective treatment, proton pump inhibitors, somatostatin, and analgesia. On POD 10, the heart rate was 170 beats/minute, BP was 108/59 mmHg, leucocyte count was 13.15 × 10^9^ cells/L, and drainage amylase level was 145.5 U/L. Reexamination using total abdominal CT suggested bilateral subdiaphragmatic free gas, abdominal and pelvic effusion, anastomotic leakage (Fig. [3](#Fig3){ref-type="fig"}a), expansion of the upper abdominal bowel, effusion, and obstruction (Fig. [3](#Fig3){ref-type="fig"}b). Subsequently, the patient appeared to be unconscious, and he was given assisted breathing by endotracheal intubation ventilation, continuous renal replacement therapy (CRRT), and peritoneal puncture and drainage under ultrasound guidance. About 1000 ml of yellow-green fluid was extracted, and the level of amylase in the drainage fluid was 896.3 U/L. Fig. 3On POD 10, CT showed (**a**) bilateral subphrenic and intraperitoneal free gas and abdominal pelvic effusion; (**b**) dilatation and effusion of upper abdominal intestine

Considering anastomotic leakage, acute diffuse peritonitis, and septic shock, the patient underwent a second exploratory laparotomy. During the operation, the superior mesenteric vessels were found to be compressing the jejunum, resulting in obvious dilation of the jejunum loop in the upper colon region, and the jejunum in the lower colon region was empty. In front of the pancreatojejunostomy location, there was a leak with a diameter of about 5 mm, and a large amount of fluid surrounded the liver and spleen. A retrograde gastric tube was implanted in the jejunum from the proximal end of the Braun anastomosis to near the chojejunostomy location, a nutrition tube was implanted in the distal jejunum under the Braun anastomosis, several silicone drainage tubes were placed around the liver, spleen, and pelvis, and the operation was completed (Fig. [4](#Fig4){ref-type="fig"}a and Fig. [4](#Fig4){ref-type="fig"}b). Fig. 4(**a**) Abdominal incision and drainage tube after secondary operation;(**b**) Schematic diagram of drainage tube in secondary operation

On the post-second operative day (PSOD) 1, the patient's temperature was 37.9 °C, pulse rate was 90 times/minute, BP was 120/70 mmHg, and the endotracheal tube was removed after the patient awoke. Following that, enteral nutrition was performed, peritoneal lavage and drainage were continued, and anti-infective agents, proton pump inhibitors, somatostatin, and other treatments were continued. On PSOD 32, the patient's pancreatic fistula was healed and the abdominal drainage tube was removed. The patient was discharged on PSOD 35. On PSOD 45, the nutrition tube was removed and the gastric tube in the jejunum loop was removed, indicating full recovery of the patient.

Discussion and conclusion {#Sec3}
=========================

Thanks to advances in surgical techniques and perioperative management, the current mortality rate after PD procedures has decreased to less than 5% in high-volume centers \[[@CR11], [@CR12]\], but the postoperative morbidity remains high with a complication rate of at least 45% \[[@CR13], [@CR14]\]. Pancreatic anastomosis is the "Achilles heel" of pancreatic resection and POPF, and is a common complication following PD procedures \[[@CR15]\]. The spectrum of POPF cases can be mild to severe. The International Study Group of Pancreatic Surgery (ISGPS) stratifies POPFs into three risk grades \[[@CR16]\]. Grade A POPF is mild and of no clinical importance, while Grade B POPF mandates a change in postoperative management or requires prolonged drainage for more than 3 weeks post-surgery, potentially increasing the incidence of infection. Grade C POPF can lead to acute hemorrhage and abdominal sepsis, increasing both morbidity and mortality.

It is known that several factors contribute to the development of a POPF. There are technical and perioperative factors, on the one hand, and patient-related factors, on the other hand \[[@CR17]\]. In 2013, Callery et al. identified several perioperative factors related to the occurrence of POPF, such as soft pancreatic tissue, a small pancreatic duct diameter of \< 3 mm, and a body mass index ≥25 kg/m^2^ \[[@CR6]\]. Other less investigated patient factors, such as body composition parameters (i.e. sarcopenia, obesity, and the combination of these two parameters) \[[@CR18], [@CR19]\], and perioperative hyperhydration have been associated with a higher risk of CR-POPF \[[@CR20], [@CR21]\].

A recent meta-analysis \[[@CR22]\] comparing duct-to-mucosa anastomosis and invagination pancreatojejunostomies showed that the rate of POPF was approximately 20% without significant differences between the two reconstruction methods. However, some non-randomized, retrospective studies have recently reported the safety and feasibility of Blumgart anastomosis, a pancreaticojejunostomy method, showing its low postoperative mortality rate (1--3%), reoperation rate (5--7%), and acceptable POPF rate (15--20%). Furthermore, these studies have shown that Blumgart anastomosis is more effective with respect to other pancreatic anastomoses, minimizing severe complications \[[@CR23]--[@CR26]\]. However, all these studies were retrospective, their impact on the clinical evidence was poor, and they require confirmation by a randomized controlled trial.

In this case, we retrospectively found that the occurrence of pancreatic leakage was due to technical defects. The pancreaticojejunostomy was completed following the lifting of the jejunum loop behind the superior mesenteric vessels, the superior mesenteric vessels compressed the loop, causing obstruction of the loop, and the pressure in the intestinal cavity of the loop was increased due to the accumulation of digestive fluid, eventually leading to rupture of the pancreaticojejunostomy. Fortunately, laparotomy was performed actively and a retrograde gastric tube was implanted in the jejunum from the proximal end of the Braun anastomosis to near the chojejunostomy location, playing a positive role in the decompression of the jejunal loop. A nutritional tube was implanted into the distal jejunum to address the patient's enteral nutrition problems. Eventually, the patient recovered and has survived to this day.

In pancreaticoduodenectomy, lifting the distal jejunum behind the superior mesenteric vessels to complete the pancreaticojejunostomy and choledochojejunostomy could lead to possible risk of jejunal loop obstruction due to compression of the superior mesenteric vessels and may also cause serious consequences such as pancreaticojejunostomy rupture or choledochojejunostomy rupture, therefore, surgeons should avoid lifting the jejunal loop behind the superior mesenteric vessels. Grade C POPF after pancreaticojejunostomy is a serious challenge for pancreatic surgeons. Various factors that contribute to POPF development have been reported in the previous literature, but there is no report that compression of the superior mesenteric vessels on the loop of the jejunum leads to POPF. This case may serve as a warning to pancreatic surgeons.
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